Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 6Rectal Neoplasms 3Esophageal Neoplasms 3Colonic Neoplasms 3Stomach Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Carcinoma, Hepatocellular 2Liver Neoplasms 1Insulin-Like Growth Factor I, Resistance To 1

Interventions

Gemcitabine 69Fluorouracil 44pembrolizumab 43Oxaliplatin 42Capecitabine 40Bevacizumab 37Leucovorin 36Irinotecan 31Cisplatin 27Nivolumab 24Paclitaxel 21Cetuximab 21Panitumumab 20130-nm albumin-bound paclitaxel 20Sorafenib 18Albumin-Bound Paclitaxel 18Drug Therapy 15Docetaxel 15Cyclophosphamide 15Radiotherapy 14Blood Specimen Collection 14IFL protocol 12atezolizumab 11Exercise 11Taxes 10budigalimab 9Erlotinib Hydrochloride 9trametinib 8Folfox protocol 8Carboplatin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Receptor Protein-Tyrosine Kinases × Gastrointestinal × Clear all
NCT01804179 2022-09-10

Colorectal Cancer Awareness, Research, Education and Screening (CARES)

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
514 enrolled
Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT00683358 2009-05-07

Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer

Tokyo University

Phase 1/2 Unknown
14 enrolled
Gastrointestinal

Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡